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Abstract
Atherosclerosis-related diseases are the leading cause of morbidity or mortality in the
world. They result in serious outcomes such as sudden cardiac death, unstable angina
pectoris, acute myocardial infarction, stroke, or intermittent claudication due to vessel
obliteration or plaque rupture with subsequent thrombosis. There are some limita‐
tions with standard treatments such as antiplatelet drugs, angiotensin-converting
enzyme inhibitors, beta-blockers, coronary artery bypass surgery, and percutaneous
transluminal coronary angioplasty. Therefore, complementary and alternative
medicine is necessary for medication. Traditional Chinese medicine is the main
complementary therapy used in the Chinese community. This article aims to explore
complementary therapy with traditional Chinese medication for atherosclerosis-
related diseases. There is some scientific evidence to support that traditional Chinese
medicine could treat atherosclerosis and its associated conditions. Acupuncture
through needling on ST36, ST40, PC6, or BL15 could alleviate atherosclerosis-related
cardiovascular diseases. Tai chi and meditation have beneficial effects for mental and
physical health. In addition, extracts or compounds of single Chinese herbs such as
Salvia miltiorrhiza, Panax notoginseng, Ginkgo biloba, Curcuma longa, Crataegus pinnatifi‐
da, Paeonia lactiflora, Prunella vulgaris, Polygonum multiflorum, Coptis chinensis, and red
yeast rice also could treat atherosclerosis-related diseases through their endothelial
protective, antioxidative, anti-inflammatory, inhibiting of smooth muscle cells
proliferation, and lipid-lowering effects. In accordance with evidence-based medi‐
cine, well-designed and conducted clinical studies such as randomized control clinical
trials will be necessary in the future.
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1. Introduction
Atherosclerosis is the most common type of arteriosclerosis. It is a disease of the arteries
characterized by the deposition of fatty plaques on their inner walls, which hardens or narrows
medium to large blood vessels, especially the aorta, coronary arteries, and cerebral arteries [1].
Atherosclerosis-related diseases often lead to serious outcomes such as sudden cardiac death,
unstable angina pectoris, acute myocardial infarction, stroke, and intermittent claudication
due to vessel obliteration or plaque rupture with subsequent thrombosis [1,2]. Epidemiological
studies indicate that, because of the adoption of Western lifestyle, the prevalence of athero‐
sclerosis is increasing all over the world and will likely reach epidemic proportions in the
coming decades [2]. The earliest visible lesion in the development of atherosclerosis is the fatty
streak. It consists of aggregates of foam cells (i.e., lipoprotein-loaded macrophages) in the
subendothelial space. Fatty streaks may also include T cells, aggregated platelets, and smooth
muscle cells. A fatty streak is the precursor lesion of an atheroma that may become an
atheromatous plaque [2]. In response to plaque growth, the arterial wall can remodel itself by
increasing its external diameter to accommodate the plaque without narrowing the lumen.
Thrombosis is the last stage in the disease process that is responsible for clinically observable
adverse events mentioned previously.
Traditional Chinese medicine (TCM), especially herbal medicine, has been used for the
treatment of cardiovascular diseases for hundreds of years, as documented in the Yellow
Emperor's Inner Canon (Huangdi Neijing) and the Essential Prescriptions from the Golden Cabinet
(Jin Gui Yao Lue). In Taiwan, Chinese herbal medicine is commonly used as complementary
and alternative therapy for the treatment of cardiovascular-related diseases such as hyperten‐
sion, dyslipidemia, and stroke. Thus, studies of the medicines used for the prevention and
treatment of atherosclerosis have received much attention in the recent years. The cellular and
molecular details regarding the underlying efficacious mechanisms of Chinese herbal medi‐
cine in treating atherosclerosis have just begun to be understood. Therefore, the purpose of
this article is to present a brief description of the mechanisms of atherogenesis and to sum‐
marize the recent research results regarding the mechanisms of antiatherogenic Chinese herbal
compounds commonly used in clinical practice. Other interventions of TCM such as acupunc‐
ture, tai chi and meditation will also be briefly discussed.
2. Pathology and risk factors of atherosclerosis
The pathology of atherosclerosis is a progressive process with increasing age that is related to
some risk factors such as hypertension, hyperlipidemia, diabetes mellitus, obesity, and
cigarette smoking [1]. Atherosclerosis begins with damage to the endothelium, which results
in endothelial vasodilator dysfunction. The endothelium subsequently cannot modulate tone,
growth, hemostasis, and inflammation throughout the circulatory system. Injured endothelial
cells (EC) produce cell surface adhesion molecules such as vascular cell adhesion molecule-1
(VCAM-1), and thereby cause monocytes and T-lymphocytes to adhere to the endothelium
and migrate beneath it [1,2]. Circulating monocytes and T-lymphocytes provoke an inflam‐
matory response. The tight junctions between EC loosen and increase the permeability to
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lipids, especially low-density lipoprotein (LDL). Once the oxidation of LDL has crossed the
damaged endothelium into the intima, monocytes differentiate into macrophages and begin
to take up oxidized LDL [1]. Macrophages bite and retain the lipid, and then become foam
cells. The fatty streak consisting of lipid-containing foam cells in the arterial wall can evolve
into atherosclerotic plaques or atheromas [1]. In addition, T-lymphocytes secrete cytokines that
induce vascular smooth muscle cells to migrate from the media to the intima and proliferate
shortly thereafter [1]. Over time, a growing lesion consisting of lipid and smooth muscle cells
invade and narrow the lumen of the artery. Other extracellular matrix (ECM) components such
as collagen, elastin, glycoprotein, and proteoglycans give tensile strength and viscoelasticity
to the arterial wall. Increasing the synthesis of ECM components such as matrix metallopro‐
teinases (MMPs) contributes significantly to ECM destruction, which renders the plaque more
prone to rupture [1]. Once a plaque ruptures, it can trigger an acute thrombosis or embolism
by activating platelets. It may finally lead to myocardial infarction, stroke, and even death.
3. Conventional treatment of atherosclerosis
Atherosclerosis treatment usually begins with lifestyle changes such as a low cholesterol diet,
regular exercise, and quitting smoking. Depending on the severity of the disease, a person may
be prescribed oral medication such as antiplatelets, angiotensin-converting enzyme (ACE)
inhibitors, or beta-blockers. In patients with advanced disease, certain medical procedures
such as percutaneous transluminal coronary angioplasty or coronary artery bypass surgery
may be necessary.
4. Status and purpose
Conventional medical costs paid by patients or by the Bureau of National Health Insurance
(Taipei, Taiwan) are expensive. The caregiver burden on the patients’ families and government
has increased yearly. In addition, conventional therapies for atherosclerosis-related diseases
have some limitations such as statin-induced rhabdomyolysis or hepatitis, and antiplatelet
agent-related gastrointestinal bleeding or peptic ulcer. Complementary and alternative
therapy is another option for atherosclerosis medication. Traditional Chinese medicine is the
primary complementary therapy used in the Chinese community. The aim of this paper is to
explore complementary therapy with traditional Chinese medication for treating atheroscle‐
rosis-related diseases.
5. Atherosclerosis corresponds to blood stasis syndrome
According to TCM theory, obstructed circulation of blood results in blood stasis syndrome
(Xue Yu), which is an important pattern of slowing or retardation of the blood circulation. The
main symptoms may include stabbing pain with a fixed position, tenderness, local purpura,
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lumps, dark-purple lips and finger nails, a blue-purple tongue, and a thready or hesitant pulse.
Blood stasis syndrome in TCM corresponds to atherosclerosis in modern Western medicine.
Both blood stasis syndrome and atherosclerosis are the predevelopment or initial stage of
ischemic heart disease, myocardial infarction, or stroke (Figure 1). With early treatment by
medication, the progression of cardiovascular or cerebral vascular disease will not worsen.
Figure 1. Progression from health to cardiovascular or cerebrovascular disease. EKG, electrocardiogram.
6. Atherosclerosis-related cardiovascular or cerebral vascular diseases
Table 1 shows atherosclerosis-related cardiovascular or cerebrovascular diseases. Atheroscle‐
rosis can cause embolism, thrombosis, ischemia, infarction, stenosis, or occlusion of the
arteries. Some Chinese herbs can promote blood circulation or remove blood stasis and may
be useful for treating atherosclerosis-related diseases.
ICD-9-CM Diseases
4140 Coronary atherosclerosis
4400 Atherosclerosis of the aorta
4149 Chronic ischemic heart disease, unspecified
4148 Other specified forms of chronic ischemic heart disease
4118 Other acute and subacute forms of ischemic heart disease
410 Acute myocardial infarction
4110 Postmyocardial infarction syndrome
412 Old myocardial infarction
4297 Other certain sequelae of myocardial infarction, not elsewhere classified
444 Arterial embolism and thrombosis
4292 Cardiovascular disease, unspecified
433 Occlusion and stenosis of precerebral arteries
434 Occlusion of cerebral arteries
ICD-9-CM, International Classification of Diseases, 9th Revision, Clinical Modification (US Centers for Disease Control and
Prevention (CDC), Salt Lake City, Utah; 1996).
Table 1. Atherosclerosis-related cardiovascular or cerebrovascular diseases
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7. Chinese single herbs and atherosclerosis-related diseases
7.1. Effect of herbal extracts/compounds on the initiation of an atherosclerotic lesion
Several strategies exist for the treatment of atherosclerosis and associated diseases such as risk
factor modification, antioxidation, anti-inflammation, and antiplatelet accumulation. Hyper‐
cholesterolemia, a primary risk factor that leads to atherosclerosis, is associated with the
development and progression of atherosclerosis. Hypercholesterolemia and endothelial injury
lead to the infiltration of LDL particles into the subendothelial space. Lowering cholesterol can
provide the initial blockade [2].
The 10 traditional Chinese herbs commonly used in clinical practice that reportedly reduce the
production of LDL and/or oxidative LDL are Salvia miltiorrhiza [3], Panax notoginseng [4], Ginkgo
biloba [5], Curcuma longa [6], Crataegus pinnatifida [7], Paeonia lactiflora [8], Prunella vulgaris [9],
Polygonum multiflorum [10], Coptis chinensis [11,12], and red yeast rice [13]. Single compounds
or crude extracts isolated from Salvia miltiorrhiza [3], Ginkgo biloba [14], Prunella vulgaris [9],
Polygonum multiflorum [15], and red yeast rice [16] restore epithelial function by regulating the
endothelial nitric oxide synthase/nitric oxide (eNOS/NO) pathway. Oxidized low-density
lipoprotein (ox-LDL) in the absence of high-density lipoprotein (HDL) can stimulate EC
activation and subsequent expression of adhesion molecules such as the vascular cell adhesion
molecule (VCAM-1) and the intercellular adhesion molecule (ICAM-1) [17]. These adhesion
molecules recruit circulating macrophages and T-lymphocytes into the subintima; this action
is mediated by macrophage chemoattractant protein-1 (MCP-1) [17].
As Table 2 shows, single compounds and/or herbal extracts from these 10 TCM herbs inhibit
the expression of adhesion molecules (i.e., VCAM-1 and ICAM-1). Among them, Salvia
miltiorrhiza [3], Panax notoginseng [4], and Coptis chinensis [18] can downregulate the expression
of MCP-1. Furthermore, ox-LDL can stimulate macrophages and T-lymphocytes to produce
inflammatory cytokines such as interleukin-1-beta (IL-1β) and tumor necrosis factor alpha
(TNF-α) in the vessel wall, which further activate EC and promote vascular smooth muscle
cell (VSMC) proliferation and migration [1]. Salvia miltiorrhiza [3], Curcuma longa [19], Paeonia
lactiflora [8], and Coptis chinensis [18] suppress the expression of TNF-α. Nuclear factor kappa
B (NF-κB) can regulate the expression of multiple inflammatory cytokines such as MCP and
cell adhesion molecules (e.g., ICAM-1 and VCAM-1) so as to affect the atherogenic process.
Most of the 10 TCM herbs can block the NF-κB pathway involved in the inflammatory process
(Table 2).
7.2. Effect of herbal extracts/compounds on the propagation of an atherosclerotic lesion
Stimulated by inflammatory cytokines such as interleukin-1α (IL-1α) and TNF-α, VSMCs
propagate and migrate from the media to the intima and produce collagen, which forms the
substance of the fibrous cap of the mature lesion [1,20]. Signaling interactions between CD40-
and CD40L-expressing cells result in the formation of matrix metalloproteinases (MMPs),
which degrade collagens and the thin fibrous cap and lead to the formation of vulnerable
plaques and rupture [20]. Among the 10 TCM herbs, Salvia miltiorrhiza [3] and Panax notogin‐
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seng [21] reduce the expression of CD40 and the activity of MMP-2. In addition, Ginkgo biloba
[22], Curcuma longa [19,23], Crataegus pinnatifida [24], Coptis chinensis [25], and red yeast rice
[26] have an inhibitory effect on MMP-2 and/or MMP-9. Table 3 summarizes the target
activities of these herbal extracts or compounds in atherosclerosis.
Salvia miltiorrhiza has been widely used in the Chinese population for treating cardiovascular
and cerebrovascular diseases. Its specific clinical use is for angina pectoris, hyperlipidemia,
and acute ischemic stroke [27], which are all closely associated with atherosclerosis. According
to TCM theory, Salvia miltiorrhiza promotes blood circulation, removes blood stasis, and
relieves pain. Several compounds derived from Salvia miltiorrhiza have been well studied in
the treatment of atherosclerosis. Protocatechuic aldehyde derived from Salvia miltiorrhiza
inhibits lipopolysaccharide-induced human umbilical vein EC apoptosis via the regulation of
Herb/
interventions
eNOS/
NO
LDL/ox-
LDL
VCAM-1 ICAM-1 MMP-9/2 CD40 MCP-1 NF-κB TNF-α
Salvia miltiorrhiza ↑  [3] ↓  [3] ↓  [3] ↓  [3] ↓  [3] ↓  [3] ↓  [3] ↓  [3] ↓  [3]
Panax notoginseng ↓  [4] ↓  [38] ↓  [38] ↓  [21] ↓  [21] ↓  [4] ↓  [4]
Ginkgo biloba ↑  [14] ↓  [5] ↓  [39] ↓  [39] ↓  [22] ↓  [40]
Curcuma longa ↓  [41] ↓  [6] ↓  [6] ↓  [19,23] ↓  [23] ↓  [19]
Crataegus pinnatifida ↓  [7] ↓  [24] ↓  [24] ↓  [24]
Paeonia lactiflora ↓  [8] ↓  [42] ↓  [43] ↓  [43] ↓  [8]
Prunella vulgaris ↑  [9] ↓  [9] ↓  [38] ↓  [38] ↓  [38]
Polygonum
multiflorum
↑  [15] ↓  [10] ↓  [39] ↓  [39]
Coptis chinensis ↓  [11, 12] ↓  [40] ↓  [40] ↓  [25] ↓  [18] ↓  [25] ↓  [18]
Red yeast rice ↑  [16] ↓  [13] ↓  [41] ↓  [42] ↓  [26] ↓  [26, 41]
Acupuncture ↑  [38] ↓  [39] ↓  [39] ↓  [41] ↓  [39] ↓  [40]
Tai chi/yoga ↓  [42,43]
The up arrow (↑ ) indicates increased expression; the down arrow (↓ ) indicates decreased expression.
eNOS, endothelial nitric oxide synthase; ICAM-1, intercellular adhesion molecule; LDL, low-density lipoprotein; MCP-1,
macrophage chemoattractant protein; MMP-9, matrix metalloproteinase-9; NF-κB, nuclear factor-kappaB; NO, nitric
oxide; ox-LDL, oxidized low-density lipoprotein; TNF-α, tumor necrosis factor alpha; VCAM-1, vascular cell adhesion
molecule-1.
Table 2. Multiple signaling molecules involved in atherosclerosis and regulated by Chinese herbs
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Herbs Compound/extract Target Reference
Salvia miltiorrhiza Protocatechuic
Aldehyde
Reduce caspase-3, and VSMC migration
and proliferation
[28,29]
Cryptotanshinone Increase NO; reduce ox-LDL, ICAM-1, VCAM-1, and
monocyte adhesion
[30]
Tanshinone IIA Reduce ROS, Bax/Bcl-2, caspase-3, LOX-1,
NF-κB, ox-LDL, monocyte adhesion, VSMC
migration and proliferation, macrophage,
cholesterol accumulation, CD 40, TNF-α
MMP-2, MMP-9, and platelet aggregation
[34,35,36,43,49]
Salvianolic acid B Reduce ICAM-1, E-selectin, NF-κB, ox-LDL,
MMP-2, and MMP-9
[31-33]
Panax notoginseng Panax notoginseng
Saponins
Reduce ICAM-1, VCAM-1, ox-LDL, IL-1β, MMP-9,
MMP-2,
NF-κB, CD40, and MCP-1
[4,21,38]
Ginkgo biloba Ginkgo biloba
Extract
Increase eNOS/NO; Reduce LDL, VCAM-1, ICAM-1,
E-selectin, MMP-2, and NF-κB
[5,14,22,39,40]
Curcuma longa Curcumin Reduce LDL, VCAM-1, ICAM-1, MMP-2, MMP-9,
TNF-α, and NF-κB
[6,19,23,41]
Crataegus
pinnatifida
Crataegus pinnatifida
extract
Reduce LDL, VCAM-1, ICAM-1, and MMP-9 [7,24]
Paeonia lactiflora Paeonol Reduce VCAM-1, ICAM-1, and TNF-α [42,43]
Total glucosides of peonyReduce LDL and TNF-α [8]
Prunella vulgaris Prunella vulgaris extract Increase eNOS/NO; reduce LDL, VCAM-1,
ICAM-1, and NF-κB
[9,38,44]
Polygonum
multiflorum
2,3,5,4'-
tetrahydroxystilbene-2-
O-beta-D-glucoside
(TSG)
Increase eNOS/NO; reduce LDL,
VCAM-1, and ICAM-1
[10,15,39,45]
Coptis chinensis Berberine Reduce LDL, ox-LDL, VCAM-1, ICAM-1, MMP-9,
MCP-1, NF-κB, and TNF-α
[11,12,18,25,40,
46]
Red yeast rice Monascus purpureus-
fermented rice extract
Increase eNOS/NO; reduce LDL, VCAM-1, ICAM-1,
MMP-9, MMP-2, and NF-κB
[13,16,26,41,42,
47,48]
eNOS, endothelial nitric oxide synthase; ICAM-1, intercellular adhesion molecule; IL-1β, interleukin 1β; LDL, low-density
lipoprotein; LOX1, lectin-like oxidized low-density lipoprotein receptor-1; MCP-1, macrophage chemoattractant protein;
MMP, matrix metalloproteinase; NF-κB, nuclear factor-kappaB; NO, nitric oxide; ox-LDL, oxidized low-density
lipoprotein; ROS, reactive oxygen species; TNF-α, tumor necrosis factor alpha; VCAM-1, vascular cell adhesion
molecule-1; VSMC, vascular smooth muscle cells.
Table 3. The target activity of herbal extracts or compounds in atherosclerosis
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caspase-3, the migration and proliferation of VSMC, and intravascular thrombosis [28,29].
Cryptotanshinone derived from Salvia miltiorrhiza suppresses the increase in endothelial
permeability, which is likely because of the restoration of NO bioavailability in EC. Crypto‐
tanshinone also can attenuate monocyte adhesion to EC through inhibiting the expression of
adhesion molecules. Salvianolic acid B, a water-soluble antioxidant obtained from Salvia
miltiorrhiza, can reduce oxidative stress, inhibit LDL oxidation, and reduce oxidized LDL-
induced cytotoxicity [31]. Salvianolic acid B also inhibits VCAM-1 and ICAM-1 expression in
TNF-α-treated human aortic EC, and attenuates MMP-2 and MMP-9 expression in vivo in
apolipoprotein E-deficient mouse aorta and in vitro in LPS-treated human aortic smooth
muscle cells [32,33].
Tanshinone IIA, another compound derived from Salvia miltiorrhiza, markedly inhibits the
elevation of ROS evoked by hydrogen peroxide. Tanshinone IIA significantly decreases the
hydrogen peroxide-induced expression of proapoptotic proteins Bax and caspase-3 and
significantly increases the expression of antiapoptotic protein Bcl-2 in EA.hy926 cells [34].
Tanshinone IIA inhibits oxidized LDL-induced lectin-like oxidized low-density lipoprotein
receptor-1 (LOX1) expression in macrophages by reducing intracellular superoxide radical
generation and NF-κB activation [35]. Tanshinine IIA also reduces the expression of CD 40,
TNF-α, MMP-2, MMP-9, and suppresses VSMC migration and proliferation, macrophage
cholesterol accumulation, and platelet aggregation [36].
Hung et al. [37] report that a low dose (0.015 mg/mL) of Salvia miltiorrhiza aqueous extract
significantly inhibited the growth of a rat smooth muscle cell line (i.e., A10) under Homocys‐
teine(Hcy) stimulation, and Salvia miltiorrhiza aqueous extract treatment decreased the
intracellular reactive oxygen species (ROS) concentration in terms of reducing p47 (phox)
translocation and increasing catalase activity. The signaling profile suggests that Salvia
miltiorrhiza aqueous extract inhibits Hcy-induced A10 cell growth via the protein kinase C/
mitogen-activated protein kinase (PKC/MAPK)-dependent pathway [37].
8. Acupuncture and atherosclerosis-related diseases
In addition to herbal medicine, acupuncture has been used for a long time in the treatment of
cardiovascular disease in Asia. Acupuncture is applied in the treatment of hypertension and
hyperlipidemia, which are risk factors leading to atherosclerosis. Kim et al. [50] demonstrated
that electroacupuncture on the Zusanli (ST36) (Figure 2) point reduces hypertension by
activating nitric oxide synthase signaling mechanisms [50]. Tian et al. [51] report that electro‐
acupuncture on the Fenglong (ST40) point downregulates the effect of plasma total cholesterol,
LDL, MCP-1, and ICAM-1 in hyperlipidemic rats. Another study by Xiao et al. [52] showed
that electroacupuncture on the Fenglong (ST40) point effectively lowers serum total cholesterol,
LDL, and macrophage TNF-α and IL-6 levels in hyperlipemia rats. Li et al. [53] showed that
electroacupuncture of the Neiguan (PC6) and Xinshu (BL15) points can suppress the increased
expression of CD 40 L and MMP-9 proteins of coronary artery tissue in rats with coronary
atherosclerotic heart disease.
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Figure 2. The World Health Organization (WHO) standard acupuncture point locations of ST36, ST40, PC6, and BL15 [54].
9. Mind–body exercise of tai chi and yogi
Tai chi chuan (tai chi) is a Chinese traditional mind–body exercise with low to moderate exercise
intensity. Previous studies have shown that it offers benefits for aerobic capacity, muscular
strength, balance, and cardiovascular risk factors such as hypertension, diabetes mellitus, and
dyslipidemia. Furthermore, tai chi appears to be safe and effective for patients with acute
myocardial infarction, coronary artery bypass grafting surgery, congestive heart failure, and
stroke [55]. A study conducted in India shows that regular yogic practices can significantly
reduce blood pressure, heart rate, body fat, total cholesterol, triglycerides, and LDL.These
reactions are beneficial for cardiac and hypertensive patients [56].
10. Meditation, mind, and atherosclerosis
Certain mental disorders and stress are conducive to atherosclerosis. Kroenke et al. [57]
revealed that a negative mood is predictive of a greater progression of calcified atherosclerosis,
compared to a positive mood. Everson-Rose et al. [58] found that high levels of stress, hostility,
and depressive symptoms are associated with a significantly increased risk of incident stroke
or transient ischemic attacks in middle-aged and older adults. Stillman et al. [59] and Wang et
al. [60] also noted that anxiety can potentially predict a worse outcome through worsening of
vascular function in patients with coronary atherosclerotic disease.
Meditation is an alternative medicine practice for mental and physical health. It has salutary
effects on patients with anxiety [61, 62], depression [61, 63], and stress [64, 65]. Some articles
report that meditation can calm the emotions and produce beneficial effects on the cardiovas‐
cular system, particularly with regard to vascular aspects [66-68]. Walton et al. [68] advocate
meditation to reduce traditional and novel risk factors for cardiovascular diseases; for example,
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meditation (1) decreases blood pressure; (2) reduces the use of tobacco and alcohol; (3) lowers
the cholesterol level and lipid oxidation; and (4) decreases psychosocial stress.
The mechanism and neurobiological effects of mindfulness meditation involve (1) deactivation
of the default mode network, which generates spontaneous thoughts, contributes to the
maintenance of the autobiographical self, and is associated with anxiety and depression; (2)
the anterior cingulate cortex, which underpins attention functions; (3) the anterior insula,
which is associated with the perception of visceral sensation, the detection of the heartbeat and
respiratory rate, and the affective response to pain; (4) the posterior cingulate cortex, which
helps one to understand the context from which a stimulus emerges; (5) the temporoparietal
junction, which assumes a central role in empathy and compassion; and (6) the amygdala,
which is implicated in fear responses [69].
11. Further research
There are few studies on formulas or single herbal drugs interaction in the treatment of
atherosclerosis. In accordance with evidence-based medicine, well-designed and conducted
clinical studies such as randomized control clinical trials will be necessary in the future.
12. Conclusions
Atherosclerosis-related diseases are the primary causes of death. In addition to standard
treatment, complementary therapy needs to be face up. Traditional Chinese medicine is a
popular complementary and alternative medicine (CAM) in East Asia and throughout the
world. There is increasing scientific evidence demonstrating that TCM has potential for
treating atherosclerosis and its associated conditions. Acupuncture, tai chi, and meditation
have beneficial effects for atherosclerosis-related cardiovascular diseases. Extracts or com‐
pounds of single herbs of some Chinese herbs such as Salvia miltiorrhiza, Panax notoginseng,
Ginkgo biloba, Curcuma longa, Crataegus pinnatifida, Paeonia lactiflora, Prunella vulgaris, Polygonum
multiflorum, Coptis chinensis, and red yeast rice through their endothelial protective, antioxi‐
dative, anti-inflammatory, and lipid-lowering effects may act on multiple mechanisms
involved in the pathogenesis of atherosclerosis.
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